Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CytRx
CytRx
CytRx Names Industry Veteran as President and COO
CP Wire
Thu, 05/3/18 - 11:02 pm
CytRx
CytRx Names Industry Veteran as President and COO
Thu, 05/3/18 - 12:25 pm
CytRx
Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug
Endpoints
Fri, 07/28/17 - 11:33 am
biotech
Dr. Patrick Soon-Shiong
CytRx
NantCell
NantWorks
doxorubicin
soft tissue sarcoma
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1
TheStreet.com
Wed, 04/12/17 - 06:09 pm
biotech
ImmunoCellular Therapies
Lion Biotechnologies
Anavex Life Sciences
Galena Biopharma
CytRx
OncoSec
NeoStem
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
CytRx CEO Pockets Millions of Dollars as Failed Sarcoma Drug Moves to FDA
TheStreet.com
Tue, 11/29/16 - 09:54 am
CytRx
Pharma CEOs
aldoxorubicin
sarcoma
FDA
FDA removes partial clinical hold on CytRx's aldoxorubicin clinical trials
News-medical.net
Tue, 01/20/15 - 09:23 am
FDA
CytRx
aldoxorubicin
cancer
Cytrx cancer drug shows promise in mid-stage study
Yahoo/Reuters
Tue, 01/6/15 - 08:46 am
CytRx
aldoxorubicin
brain cancer
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off
TheStreet.com
Tue, 12/2/14 - 07:31 pm
MediciNova
Agenus
CytRx
CTI BioPharma
Sunesis
FDA puts partial hold on CytRx cancer drug trials
Yahoo/Reuters
Tue, 11/18/14 - 09:09 am
FDA
CytRx
clinical trials
aldoxorubicin
CytRx is pouring money into R&D of cancer-fighting drugs
LA Times, CA
Mon, 09/1/14 - 09:52 am
R&D
cancer
CytRx
Biotech Stock Mailbag: Threshold, Galena, CytRx
TheStreet.com
Fri, 08/22/14 - 12:04 pm
Threshold Pharmaceuticals
Galena Biopharma
CytRx
CytRx presents aldoxorubicin Phase 2b trial data
Yahoo/Fly on the Wall
Thu, 04/24/14 - 07:59 am
aldoxorubicin
CytRx
CytRx Misled Investors According to a Recently Filed Class Action
Yahoo/PR NewsWire
Sat, 03/22/14 - 11:33 am
CytRx
lawsuits
Harwood Feffer LLP Announces Investigation of CytRx Corporation
Yahoo/PR NewsWire
Sat, 03/15/14 - 10:04 am
CytRx
3 Newsworthy Biotech Stocks: BioDelivery, CytRx, TG Therapeutics
Wall St Cheat Sheet
Mon, 02/3/14 - 10:55 am
BioDelivery Sciences
TG Therapeutics
CytRx
CytRx Flushed Its Shareholders, Even If It Needed the Capital
24-7 Wallstreet
Sat, 02/1/14 - 10:51 am
CytRx
CytRx receives FDA approval to continue aldoxorubicin clinical trial
Yahoo/Fly on the Wall
Tue, 01/21/14 - 08:28 am
CytRx
FDA
aldoxorubicin
clinical trials
soft tissue sarcomas
Spotlight 2014-Biotech CytRx Corporation
Seeking Alpha
Fri, 01/17/14 - 09:14 am
CytRx
aldoxorubicin
Progenics Likely To Announce Positive Prostate Cancer Data In January
Seeking Alpha
Tue, 01/7/14 - 09:28 am
prostate cancer
Progenics
Celldex Therapeutics
Seattle Genetics
CytRx
Adcetris
Pages
1
2
3
4
next ›
last »